FindTrial
Sign In

Whole Genome Sequencing i n advanced cancer cohort with clinical targeted sequencing

Whole Genome Sequencing i n advanced cancer cohort with clinical targeted sequencing

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007707
Enrollment
60
Registered
2022-09-16
Start date
2022-09-02
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Ajou University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Patients who have consented to the consent form for the subject and the consent form for human materials ? Patients over the age of 19 on the date of signing the consent form ? Patients who have the ability to make a written informed consent to voluntarily participate in this study ? Histologically confirmed advanced solid cancer patients (stage III or IV) ? Patients performing clinical targeted sequencing for diagnostic purposes during the treatment process

Exclusion criteria

Exclusion criteria: ? Patients who do not understand or do not consent to written consent ? Patients who do not have sufficient residual DNA of 500 ng or more after the clinical panel sequencing test ? Patients who do not consent to genetic testing

Design outcomes

Primary

MeasureTime frame
clinical validity of WGS in the patients who perfomed panel NGS—

Secondary

MeasureTime frame
correlation between WGS and panel NGS—

Countries

Korea, Republic of

Contacts

Public ContactMinsuk Kwon

Ajou University Hospital

minsuk.alex.kwon@gmail.com+82-31-219-5488

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026